Taiwanese Biotech Stocks

Caliway Biopharmaceuticals

Market Cap: NT$173.9b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Lotus Pharmaceutical

Market Cap: NT$56.6b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$52.3b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Center Laboratories

Market Cap: NT$29.8b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

Sunmax Biotechnology

Market Cap: NT$20.9b

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China.

TTY Biopharm

Market Cap: NT$18.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

Polaris Group

Market Cap: NT$16.0b

Offers biotechnology, drug testing, and contract development and manufacturing services.

YungShin Global Holding

Market Cap: NT$14.8b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Ever Supreme Bio Technology

Market Cap: NT$12.4b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.3b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

PharmaEngine

Market Cap: NT$8.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Adimmune

Market Cap: NT$7.7b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Acepodia

Market Cap: NT$7.4b

Operates as a clinical stage biotechnology company.

Savior Lifetec

Market Cap: NT$6.3b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

Mycenax Biotech

Market Cap: NT$6.3b

Provides biopharmaceutical services and solutions for drug development and production in Taiwan.

Formosa Laboratories

Market Cap: NT$6.2b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.0b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

CHO Pharma

Market Cap: NT$5.8b

Engages in research and development of biotechnology in Taiwan.

Orient Pharma

Market Cap: NT$5.7b

Engages in the development of new drugs in Taiwan and internationally.

Easywell Biomedicals

Market Cap: NT$5.1b

Develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America.

OBI Pharma

Market Cap: NT$5.0b

A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.

Pharmosa Biopharm

Market Cap: NT$4.8b

A biotechnology company, focuses on developing drugs in Taiwan.

Cenra

Market Cap: NT$4.8b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Medigen Biotechnology

Market Cap: NT$4.5b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cell therapy, advanced nucleic acid testing, generic drugs, medical beauty, and vaccine-related products in Taiwan.

Obigen Pharma

Market Cap: NT$4.2b

Engages in research, manufacturing, and promotion of biotechnology and novel botulinum toxin.

Orient EuroPharma

Market Cap: NT$4.1b

A pharmaceutical company, develops and manufactures drugs worldwide.

Maxigen Biotech

Market Cap: NT$3.8b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

SunWay Biotech

Market Cap: NT$3.7b

Focuses on professional research and development, and technical material manufacturing and processing business.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.2b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

BRIM Biotechnology

Market Cap: NT$3.2b

Engages in the research and development of drugs and therapies to combat and cure diseases in Taiwan.

Syngen BiotechLtd

Market Cap: NT$2.9b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

HeXun Biosciences

Market Cap: NT$2.8b

Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.

Vetnostrum Animal Health

Market Cap: NT$2.6b

Engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.

Allied Biotech

Market Cap: NT$2.6b

Engages in the manufacture and sale of carotenoids worldwide.

3D Global Biotech

Market Cap: NT$2.5b

Develops medical materials for human body reconstruction in China.

GlycoNex Incorporation

Market Cap: NT$2.5b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.